Sponsor Pipeline

R-Pharm International, LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
3
Recruiting
4
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
3
Phase 2/3
1
Phase 2
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05673902 Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With… Idiopathic Recurrent Pericarditis Active, Not Recruiting
NCT07625384 Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy… Still Disease Not Yet Recruiting
NCT07670546 Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE) Polymyalgia Rheumatica Active, Not Recruiting
Phase 2/3
NCT06440746 Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial… Lung Diseases, Interstitial Recruiting
Phase 2
NCT05190991 Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients… Familial Mediterranean Fever Recruiting
NCT07517575 Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic… Juvenile Idiopathic Arthritis Recruiting
NCT05092776 Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in… Familial Mediterranean Fever Active, Not Recruiting
NCT07553988 A Comparative Dose-finding Study of RS-113 in Patients With Metastatic… Metastatic Castration-resistant Prostate Cancer Active, Not Recruiting
Disease Areas
Get alerts when R-Pharm International, LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free